Morehouse School of Medicine Offering Color Genomics's New Advanced Precision Medicine Test for Hereditary Cancers
Marking its one year anniversary since launching the first-ever widely accessible breast and ovarian cancer risk test, Color Genomics announced a new cancer panel analyzing 30 genes that highly impact the most common hereditary cancers affecting both men and women. Available today, the Color Test analyzes hereditary cancer risks for breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers. The Color Test is physician ordered and includes genetic counseling by a board-certified genetic counselor.
Morehouse School of Medicine is one of several cancer centers partnered with Color Genomics on its Every Woman Program, which provides access to the Color Test at no cost for underprivileged individuals.